Please check your internet connection and try again.
# Urimax (Tamsulosin)
## Overview
Tamsulosin is a selective α1-adrenoceptor antagonist that specifically targets α1A receptors found in the prostate and bladder neck, causing smooth muscle relaxation and improved urine flow.
## Primary Indications
* Treatment of signs and symptoms of Benign Prostatic Hyperplasia (BPH).
* Off-label: Medical expulsive therapy for ureteral stones.
## Adult Dosing
* **BPH:** 0.4 mg orally once daily, taken 30 minutes after the same meal each day.
* **Maximum Dose:** 0.8 mg daily. If 0.4 mg is ineffective after 2–4 weeks, the dose may be increased to 0.8 mg.
## Pediatric Dosing
* **Safety/Efficacy:** Not established for pediatric use. Usage in children is strictly off-label and typically managed by pediatric urology specialists for specific neurogenic bladder conditions. Dosing varies by institutional protocol.
## Dose Adjustments
* **Renal Impairment:** No dosage adjustment indicated for mild to moderate impairment. Use caution in severe renal impairment (CrCl <10 mL/min).
* **Hepatic Impairment:** Avoid use in severe hepatic impairment (Child-Pugh Class C).
## Contraindications
* Known hypersensitivity to tamsulosin or any component of the product.
* Concomitant use with strong CYP3A4 inhibitors (e.g., ketoconazole, clarithromycin).
## Adverse Effects
* **Common:** Dizziness, headache, abnormal ejaculation (retrograde), rhinitis, asthenia.
* **Serious:** Orthostatic hypotension (greatest risk with initial dosing), syncope, Intraoperative Floppy Iris Syndrome (IFIS) during cataract surgery.
## Key Drug Interactions
* **CYP3A4/2D6 Inhibitors:** May significantly increase plasma concentrations of tamsulosin.
* **Antihypertensives/PDE-5 Inhibitors:** Risk of synergistic hypotensive effects; monitor blood pressure closely.
* **Alpha-1 Blockers:** Do not combine with other alpha-adrenergic antagonists to avoid excessive hypotension.
## Monitoring
* Monitor blood pressure periodically, especially during initiation or dosage titration.
* Assess symptomatic improvement of LUTS (Lower Urinary Tract Symptoms).
* Patients scheduled for cataract surgery should inform the ophthalmologist of current or prior tamsulosin use.
## Clinical Pearls
* **Administration:** Must be swallowed whole. Do not crush, chew, or open the capsule, as this alters the controlled-release mechanism.
* **First-Dose Phenomenon:** While less common than with non-selective alpha-blockers, warn patients of potential orthostasis.
* **IFIS:** Tamsulosin is the alpha-blocker most frequently associated with Intraoperative Floppy Iris Syndrome. Surgeons should be alerted prior to ocular procedures.
***
*Disclaimer: This information is for educational purposes only and does not constitute medical advice. Please consult current prescribing information (package insert) and institutional protocols before prescribing or administering medication.*
